Ryan Scott, MD
Vascular & Interventional Radiology · Phoenix, AZNPI 1871756031
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (41.2%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by Bard Peripheral Vascular, Inc. at 36.7% of the total. Reporting peaked in 2019 at $4,470 and has fallen 87.5% since, to $557 in 2025.
Across 99 payments — averaging $77.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bard Peripheral Vascular, Inc.$3K
- Stryker$2K
- Avanos Medical$1K
- Boston Scientific$273
- Kowa Pharmaceuticals America, Inc.$209
- Restor3d, Inc.$152
- plus $1K from 20 others
What the payments were for
- Consulting fees$2,80037%
- Speaking & faculty fees$1,40018%
- Travel & lodging$1492%
- Food & beverage$3,14041%
- Gifts$1382%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bard Peripheral Vascular, Inc. | 1 | $2,800 |
| Stryker(2 entities) | 27 | $1,792 |
| Avanos Medical | 1 | $1,400 |
| Boston Scientific | 11 | $273 |
| Kowa Pharmaceuticals America, Inc. | 25 | $209 |
| Restor3d, Inc. | 2 | $152 |
| Abbott | 4 | $145 |
| Inari Medical, Inc. | 1 | $137 |
| Blue Earth Diagnostics | 4 | $115 |
| Treace Medical Concepts, Inc. | 1 | $83 |
| Sirtex Medical Inc | 6 | $79 |
| Biocompatibles, Inc. | 1 | $68 |
| Angiodynamics, Inc. | 1 | $61 |
| Progenics Pharmaceuticals, Inc. | 2 | $51 |
| Merck | 1 | $33 |
| Verity Pharmaceuticals Inc. | 1 | $31 |
| Profound Medical Corp. | 1 | $23 |
| Incyte Corporation | 1 | $23 |
| Bioprotect Medical, Inc. | 1 | $23 |
| Terumo Medical Corporation | 1 | $23 |
| Cook Medical LLC | 1 | $22 |
| Johnson & Johnson | 1 | $20 |
| Dendreon Pharmaceuticals LLC | 1 | $19 |
| Novartis | 1 | $16 |
| Siemens Medical Solutions USA, Inc. | 1 | $16 |
| Immunitybio, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GRPRO 2.1$1,400
- Foot and Ankle$209
- INFINITY ADAPTIS$149
- GENERAL VASCULAR INTERVENTION$148
- AUGMENT$139
- INBONE$138
- FLOWTRIEVER CATHETER, S$137
- CT THROMBECTOMY SYSTEM KIT$137
- MICA$129
- INFINITY$114
How this compares
$7,627 in reported general payments places this provider in the 60th percentile of 80 vascular & interventional radiology providers in Arizona.
See all vascular & interventional radiology providers in Arizona →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 15 | $91 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 16 | $42 |
| Ibuprofen | 14 | $37 |
| Famotidine | 14 | $23 |
Paid to pharmacies, not to this prescriber.
Other vascular & interventional radiology in Phoenix
- Kamalani HanamaikaiPhoenix$205K
- Sandeep RaoPhoenix$28K
- Grace KnuttinenPhoenix$13K
- Patricia ThorpePhoenix$13K
- Trent DavisPhoenix$12K
- Douglas LewisPhoenix$11K
- Ankit ShahPhoenix$8K
- Sudhen DesaiPhoenix$8K
- Santiago CornejoPhoenix$7K
- Sailendra NaiduPhoenix$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.